<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="219562">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00225693</url>
  </required_header>
  <id_info>
    <org_study_id>578</org_study_id>
    <nct_id>NCT00225693</nct_id>
  </id_info>
  <brief_title>V-Flex Plus PTX Drug Eluting Coronary Stent</brief_title>
  <acronym>ELUTES III</acronym>
  <official_title>ELUTES III - V-Flex Plus PTX Drug Eluting Coronary Stent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <brief_summary>
    <textblock>
      The study is intended to collect data to evaluate effectiveness and safety of drug eluting
      stent devices in a dose ranging assessment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date>July 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double-Blind</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation by IVUS of % diameter stenosis at follow up.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse events</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization</measure>
  </secondary_outcome>
  <enrollment>150</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug eluting coronary stent</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must be eligible to undergo planned treatment of a single de novo lesion in a
             native coronary artery.

          -  Patient must be an acceptable candidate for coronary artery bypass surgery

          -  Patient or legal guardian must have given informed consent

          -  Patient agrees to return at one month for an office visit to assess cardiovascular
             status and at 6 months for an office visit to assess cardiovascular status, an IVUS
             examination and a diagnostic angiogram.

        Exclusion Criteria:

          -  Patient must be less than 18 years old

          -  Patient has history of bleeding diathesis or coagulopathy or will refuse blood
             transfusions.

          -  Patient is simultaneously participating in another investigative interventional
             cardiovascular device or drug study.

          -  Patient has known hypersensitivity or contraindication to aspirin, clopidogrel, or
             stainless steel, or a sensitivity to contrast dye.

          -  Women of child bearing potential.

          -  Patient has other medical condition that any cause non-compliance with the protocol,
             confound the results or is associated with limited life expectancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Dens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Gasthuisberg Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Sponsor</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <lastchanged_date>January 30, 2012</lastchanged_date>
  <firstreceived_date>September 12, 2005</firstreceived_date>
  <keyword>coronary artery</keyword>
  <keyword>restenosis</keyword>
  <keyword>patency</keyword>
  <keyword>drug eluting</keyword>
  <keyword>stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
